BETTER MAB Trademark

Trademark Overview


On Tuesday, November 29, 2011, a trademark application was filed for BETTER MAB with the United States Patent and Trademark Office. The USPTO has given the BETTER MAB trademark a serial number of 85482864. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 1, 2016. This trademark is owned by Intrexon Corporation. The BETTER MAB trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Chemicals, biochemicals and reagents for use in industry and science; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting cellular activity or gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in modifying and regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; antibodies for scientific and research use; antibodies for regulating, modifying or regulating cellular functions in plants, fungi and animals, and in cells of plants, fungi and animals; kits consisting primarily of proteins for regulating, modif...

Chemical preparations for medical and veterinary purposes, namely, chemical preparations for regulating, modifying, or restricting cellular activity or gene expression for purposes of treating diseases and genetic disorders; chemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for antibody therapy analysis; Pharmaceutical preparations for modifying or regulating one or more cellular functions of mammals, fungi, plants, and bacteria and transgenic mammals, fungi, plants, and bacteria; transgenic plants, fungi and bacteria for medical and veterinary purposes; antibodies for use in disease testing; all of the foregoing featuring, including or involving monoclonal antibodies or por...

Custom manufacturing and custom synthesis of antibodies and genetically engineered DNA expressing antibodies, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical, veterinary and laboratory use; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof

Development of new technology for others in the field of genetics, therapeutics and biotechnology; Development of products being antibodies and genetic therapies expressing antibodies to regulate, modulate, treat, prevent, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the fields of biotechnology and antibody technology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells expressing antibodies for scientific, research, medical, veterinary and laboratory use; Scientific research and product development services for others in the pharmaceutical, biotechnology, biosensors, bioelectronics, medical and agriculture fields; Antibody technology and gene therapy services for others for product development and scientific research purposes, namely, antibody production, gen...

Medical services; Medical services, namely, antibody and gene therapy services; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof

Technology transfer services, namely, licensing and transfer of intellectual property; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
better mab

General Information


Serial Number85482864
Word MarkBETTER MAB
Filing DateTuesday, November 29, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 1, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2012

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"MAB"
Goods and ServicesChemicals, biochemicals and reagents for use in industry and science; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting cellular activity or gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in modifying and regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; antibodies for scientific and research use; antibodies for regulating, modifying or regulating cellular functions in plants, fungi and animals, and in cells of plants, fungi and animals; kits consisting primarily of proteins for regulating, modifying or restricting cellular activity or gene expression; Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
Goods and ServicesChemical preparations for medical and veterinary purposes, namely, chemical preparations for regulating, modifying, or restricting cellular activity or gene expression for purposes of treating diseases and genetic disorders; chemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for antibody therapy analysis; Pharmaceutical preparations for modifying or regulating one or more cellular functions of mammals, fungi, plants, and bacteria and transgenic mammals, fungi, plants, and bacteria; transgenic plants, fungi and bacteria for medical and veterinary purposes; antibodies for use in disease testing; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
Goods and ServicesCustom manufacturing and custom synthesis of antibodies and genetically engineered DNA expressing antibodies, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical, veterinary and laboratory use; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
Goods and ServicesDevelopment of new technology for others in the field of genetics, therapeutics and biotechnology; Development of products being antibodies and genetic therapies expressing antibodies to regulate, modulate, treat, prevent, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the fields of biotechnology and antibody technology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells expressing antibodies for scientific, research, medical, veterinary and laboratory use; Scientific research and product development services for others in the pharmaceutical, biotechnology, biosensors, bioelectronics, medical and agriculture fields; Antibody technology and gene therapy services for others for product development and scientific research purposes, namely, antibody production, genetically engineering DNA expressing antibodies, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical, veterinary and laboratory use; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
Goods and ServicesMedical services; Medical services, namely, antibody and gene therapy services; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
Goods and ServicesTechnology transfer services, namely, licensing and transfer of intellectual property; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, December 5, 2011
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 5, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, December 5, 2011
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 5, 2011
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 5, 2011
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 5, 2011
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIntrexon Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBlacksburg, VA 24060

Party NameIntrexon Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBlacksburg, VA 24060

Trademark Events


Event DateEvent Description
Monday, February 1, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 1, 2016ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 8, 2015EXTENSION 5 GRANTED
Tuesday, June 23, 2015EXTENSION 5 FILED
Tuesday, June 23, 2015TEAS EXTENSION RECEIVED
Tuesday, December 16, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 15, 2014EXTENSION 4 GRANTED
Thursday, December 11, 2014EXTENSION 4 FILED
Thursday, December 11, 2014TEAS EXTENSION RECEIVED
Tuesday, June 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 2, 2014EXTENSION 3 GRANTED
Wednesday, May 28, 2014EXTENSION 3 FILED
Wednesday, May 28, 2014TEAS EXTENSION RECEIVED
Friday, January 31, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 30, 2014EXTENSION 2 GRANTED
Wednesday, December 4, 2013EXTENSION 2 FILED
Friday, January 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 4, 2013TEAS EXTENSION RECEIVED
Thursday, June 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 18, 2013EXTENSION 1 GRANTED
Tuesday, June 18, 2013EXTENSION 1 FILED
Tuesday, June 18, 2013TEAS EXTENSION RECEIVED
Tuesday, December 25, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 30, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 21, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 20, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 20, 2012EXAMINER'S AMENDMENT ENTERED
Thursday, September 20, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 20, 2012EXAMINERS AMENDMENT E-MAILED
Thursday, September 20, 2012EXAMINERS AMENDMENT -WRITTEN
Friday, September 7, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 7, 2012NON-FINAL ACTION E-MAILED
Friday, September 7, 2012NON-FINAL ACTION WRITTEN
Tuesday, September 4, 2012PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, August 26, 2012WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, August 10, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 10, 2012ASSIGNED TO LIE
Friday, July 27, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 27, 2012EXAMINER'S AMENDMENT ENTERED
Friday, July 27, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 27, 2012EXAMINERS AMENDMENT E-MAILED
Friday, July 27, 2012EXAMINERS AMENDMENT -WRITTEN
Friday, July 20, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 19, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 19, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 14, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 14, 2012NON-FINAL ACTION E-MAILED
Wednesday, March 14, 2012NON-FINAL ACTION WRITTEN
Monday, March 12, 2012ASSIGNED TO EXAMINER
Monday, December 5, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 2, 2011NEW APPLICATION ENTERED IN TRAM